 |
|
Effects of Benazepril and Hydrochlorothiazide, Given Alone and in Low- and High-Dose Combinations, on Blood Pressure in Patients With Hypertension
Steven G. Chrysant, MD, PhD;
Timothy Fagan, MD;
Robert Glazer, MD;
Audrey Kriegman, MD
Arch Fam Med. 1996;5(1):17-24.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Whalen J. Definition of the effective dose of the converting-enzyme inhibitor benazepril. Am Heart J. 1989;17:728-734.
2. Reams GP, Lau A, Bauer JH. Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction. J Clin Pharmacol. 1989;29:609-614.
ABSTRACT
3. Weinberger MH, Black HR, Lasseter KC, et al. Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride. Clin Pharmacol Ther. 1990;47:608-617.
PUBMED
4. Moser M, Abraham PA, Bennett WM, et al. The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study. Clin Pharmacol Ther. 1991;49:322-329.
PUBMED
5. Smith WM, Gomez HJ. The use of benazepril in hypertensive patients age 55 and over. Clin Cardiol. 1991;14(suppl_4):IV79-IV82.
PUBMED
6. Whalen J, Skalky C, DeSilva J, Weber M. Peak and trough effects of benazepril in mild-moderate hypertension. Am J Hypertens. 1989;2(5, pt 2):45A. Abstract 1178.
7. Guyene TT, Bellet M, Sassano P, Serrurier D, Corvol P, Menard J. Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension. J Hypertens. 1989;7:1005-1012.
PUBMED
8. Schoenberger JA. Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents. Am J Med. 1988;84(suppl 4A):30-35.
PUBMED
9. Bodin F, Serrurier D, Clementy J, Mugnier J, Bellet M. Efficacy of a fixed combination of benazepril and hydrochlorothiazide as first-line therapy in elderly hypertensive patients. Curr Ther Res. 1992;51:1-10.
10. Hansson L. Rationale for combination therapy. Br J Clin Pharmacol. 1987;23:S15-S19.
11. Ruoff G. ACE inhibitors and diuretics: the benefits of combined therapy for hypertension. Postgrad Med. 1989;85:137-139.
PUBMED
12. Pickering TG. The use of angiotensin converting enzyme inhibitors in combination with other antihypertensive agents. Am J Hypertens. 1991;4:73S-78S.
PUBMED
13. Chrysant SG. Antihypertensive effectiveness of low-dose lisinoprilhydrochlorothiazide combination. Arch Intern Med. 1994;154:737-743.
FREE FULL TEXT
14. Weber MA. Safety issues during antihypertensive treatments with angiotensin converting enzyme inhibitors. Am J Med. 1988;84(suppl 4A):16-23.
PUBMED
15. Shindler DM, Kostis JB. Lisinopril: mechanism of action, safety, and efficacy. Intern Med. 1989;10:92-100.
16. Kostis JB. Angiotensin converting enzyme inhibitors, II: clinical use. Am Heart J. 1988;116:1591-1605.
PUBMED
17. Chrysant SG, McDonald RH, Wright JT, et al. Perindopril monotherapy in hypertension: a multicenter comparison of two dosing regimens. Clin Pharmacol Ther. 1993;53:479-484.
PUBMED
|
